Dipeptidyl Peptidase
Read More about this categoryShow Less
Dipeptidyl Peptidase (DPP) is an antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation,signal transduction and apoptosis. DPP is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. The substrates of DPP are proline-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPP plays a major role in glucose metabolism. DPP is responsible for the degradation of incretins such as GLP-1. Furthermore, DPP appears to work as a suppressor in the development of cancer and tumours. DPP plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others.
Products Related to Dipeptidyl Peptidase(55)
- GC31444Saikogenin ACAS: 5092-09-1Purity: >98.00%
Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor.
- GC31463Gosogliptin (PF-00734200)CAS: 869490-23-3Purity: >98.50%
Gosogliptin (PF-00734200) is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-IV).
- GC31467DutogliptinCAS: 852329-66-9Purity: >99.00%
Dutogliptin (PHX-1149 free base) is an orally available, potent, and selective dipeptidyl peptidase-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.
- GC31472Retagliptin Phosphate (SP 2086)CAS: 1256756-88-3Purity: >99.50%
Retagliptin Phosphate (SP 2086) (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor.
- GC31492Vildagliptin dihydrate (LAF237 dihydrate)CAS: 2133364-01-7Purity: >98%
Vildagliptin dihydrate (LAF237 dihydrate) (LAF237 dihydrate) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells.
- GC31547DPP-IV-IN-1CAS: 625110-37-4Purity: >98%
DPP-IV-IN-1 is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV), a highly specific serine protease, with an IC50 of 4.6 nM.
- GC32546Prodipine hydrochlorideCAS: 31314-39-3Purity: >98%
Prodipine, a diphenyl-phosphonate derivative.
- GC33769Gemigliptin (LC15-0444)CAS: 911637-19-9Purity: >98%
Gemigliptin (LC15-0444) (LC15-0444 ) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4.
- GC33853Talabostat (PT100)CAS: 149682-77-9Purity: >98%
Talabostat (PT100) is an orally active and non-selective inhibitor of dipeptidyl peptidase IV (DPP-IV) ( IC 50 < 4 nM; K i = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) ( IC 50 = 560 nM), inhibiting DPP 8/9 ( IC 50 = 4/11 nM; K i = 1.5/0.76 nM), prolyl endopeptidase (QPP) (IC50= 310 nM), DPP2, and other DASH family enzymes.
- GC37594Saxagliptin hydrateCAS: 945667-22-1Purity: >99.00%
Saxagliptin hydrate is a highly potent dipeptidyl peptidase-4 (DPP-4) inhibitor that regulates blood glucose by selectively inhibiting the DPP-4 enzyme, thereby elevating levels of endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
- GC44874Saxagliptin (hydrochloride)CAS: 709031-78-7Purity: >98.00%
Saxagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4; Ki = 0.6 nM).
- GC47751Nateglinide-d5CAS: 1227666-13-8Purity: >99.00%
An internal standard for the quantification of nateglinide
- GC60828Evogliptin tartrateCAS: 1222102-51-3Purity: >99.50%
Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity.
- GC62280Teneligliptin D8CAS: 1391012-95-5Purity: >98%
Teneligliptin D8 (MP-513 D8) a deuterium labeled Teneligliptin (MP-513).
- GC63170RetagliptinCAS: 1174122-54-3Purity: >98.50%
Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor.
- GC66355Linagliptin-d4CAS: 2140263-92-7Purity: >98%
Linagliptin-d4 is deuterium labeled Linagliptin. Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
- GC68890CofrogliptinCAS: 1844874-26-5Purity: >98.00%
Cofrogliptin (HSK7653) (compound 2), a tetrahydrofuran derivative, is an effective oral DPP-4 inhibitor with long-lasting blood sugar-lowering effects. Cofrogliptin (compound 2) has great potential in the treatment of type 2 diabetes mellitus (T2DM).
- GC69900Sitagliptin fenilalanilCAS: 1339955-03-1Purity: >99.00%
Sitagliptin phenylalanine is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC31444 | Saikogenin A | 5092-09-1 | >98.00% | |
Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor. | ||||
| GC31463 | Gosogliptin (PF-00734200) | 869490-23-3 | >98.50% | |
Gosogliptin (PF-00734200) is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-IV). | ||||
| GC31467 | Dutogliptin | 852329-66-9 | >99.00% | |
Dutogliptin (PHX-1149 free base) is an orally available, potent, and selective dipeptidyl peptidase-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus. | ||||
| GC31472 | Retagliptin Phosphate (SP 2086) | 1256756-88-3 | >99.50% | |
Retagliptin Phosphate (SP 2086) (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. | ||||
| GC31492 | Vildagliptin dihydrate (LAF237 dihydrate) | 2133364-01-7 | >98% | |
Vildagliptin dihydrate (LAF237 dihydrate) (LAF237 dihydrate) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. | ||||
| GC31547 | DPP-IV-IN-1 | 625110-37-4 | >98% | |
DPP-IV-IN-1 is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV), a highly specific serine protease, with an IC50 of 4.6 nM. | ||||
| GC32546 | Prodipine hydrochloride | 31314-39-3 | >98% | |
Prodipine, a diphenyl-phosphonate derivative. | ||||
| GC33769 | Gemigliptin (LC15-0444) | 911637-19-9 | >98% | |
Gemigliptin (LC15-0444) (LC15-0444 ) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. | ||||
| GC33853 | Talabostat (PT100) | 149682-77-9 | >98% | |
Talabostat (PT100) is an orally active and non-selective inhibitor of dipeptidyl peptidase IV (DPP-IV) ( IC 50 < 4 nM; K i = 0.18 nM) and the first clinical inhibitor of fibroblast activation protein (FAP) ( IC 50 = 560 nM), inhibiting DPP 8/9 ( IC 50 = 4/11 nM; K i = 1.5/0.76 nM), prolyl endopeptidase (QPP) (IC50= 310 nM), DPP2, and other DASH family enzymes. | ||||
| GC37594 | Saxagliptin hydrate | 945667-22-1 | >99.00% | |
Saxagliptin hydrate is a highly potent dipeptidyl peptidase-4 (DPP-4) inhibitor that regulates blood glucose by selectively inhibiting the DPP-4 enzyme, thereby elevating levels of endogenous glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). | ||||
| GC37757 | Teneligliptin hydrobromide hydrate | 1572583-29-9 | >98% | |
A DPP-4 inhibitor | ||||
| GC39296 | 1G244 | 847928-32-9 | >98.50% | |
1G244 is a potent DPP8/9 inhibitor with IC50s of 12 nM and 84 nM, respectively. 1G244 does not inhibit DPPIV and DPPII. 1G244 induces apoptosis in multiple myeloma cells and has anti-myeloma effects. | ||||
| GC44353 | NDMC101 | 1308631-40-4 | >99.50% | |
A salicylanilide derivative | ||||
| GC44874 | Saxagliptin (hydrochloride) | 709031-78-7 | >98.00% | |
Saxagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4; Ki = 0.6 nM). | ||||
| GC45436 | Diprotin A | 90614-48-5 | >99.50% | |
| ||||
| GC47751 | Nateglinide-d5 | 1227666-13-8 | >99.00% | |
An internal standard for the quantification of nateglinide | ||||
| GC60613 | Azaleatin | 529-51-1 | >98% | |
Azaleatin is an O-methylated flavonol isolated from Rhododendron species. | ||||
| GC60828 | Evogliptin tartrate | 1222102-51-3 | >99.50% | |
Evogliptin tartrate is a potent, orally bioavailable and selective dipeptidyl peptidase-4 (DPP-4) inhibitor, with antidiabetic activity. | ||||
| GC62280 | Teneligliptin D8 | 1391012-95-5 | >98% | |
Teneligliptin D8 (MP-513 D8) a deuterium labeled Teneligliptin (MP-513). | ||||
| GC63170 | Retagliptin | 1174122-54-3 | >98.50% | |
Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. | ||||
| GC63383 | Sitagliptin-d4 phosphate | 1432063-88-1 | >98% | |
| GC66355 | Linagliptin-d4 | 2140263-92-7 | >98% | |
Linagliptin-d4 is deuterium labeled Linagliptin. Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. | ||||
| GC68890 | Cofrogliptin | 1844874-26-5 | >98.00% | |
Cofrogliptin (HSK7653) (compound 2), a tetrahydrofuran derivative, is an effective oral DPP-4 inhibitor with long-lasting blood sugar-lowering effects. Cofrogliptin (compound 2) has great potential in the treatment of type 2 diabetes mellitus (T2DM). | ||||
| GC69900 | Sitagliptin fenilalanil | 1339955-03-1 | >99.00% | |
Sitagliptin phenylalanine is a dipeptidyl peptidase-4 (DPP-4) inhibitor. | ||||
